Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial
- Bardia, A.
- Parton, M.
- Kummel, S.
- Estevez, L.G.
- Huang, C.-S.
- Cortes, J.
- Ruiz-Borrego, M.
- Telli, M.L.
- Martin-Martorell, P.
- Lopez, R.
- Beck, J.T.
- Ismail-Khan, R.
- Chen, S.-C.
- Hurvitz, S.A.
- Mayer, I.A.
- Carreon, D.
- Cameron, S.
- Liao, S.
- Baselga, J.
- Kim, S.-B.
ISSN: 1527-7755, 0732-183X
Datum der Publikation: 2018
Ausgabe: 36
Nummer: 31
Seiten: 3126-3133
Art: Artikel